| Previous Close | 204.57 |
| Open | 206.43 |
| Bid | 199.30 x 800 |
| Ask | 217.89 x 1300 |
| Day's Range | 201.15 - 208.73 |
| 52 Week Range | 124.60 - 231.36 |
| Volume | 1,411,822 |
| Avg. Volume | 922,319 |
| Market Cap | 59.431B |
| Beta (5Y Monthly) | 1.01 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.15 |
| Earnings Date | Apr 26, 2021 - May 03, 2021 |
| Forward Dividend & Yield | 1.92 (0.92%) |
| Ex-Dividend Date | Mar 15, 2021 |
| 1y Target Est | 222.57 |
All businesses have been affected by the COVID-19 pandemic. With that, we asked some of our contributors which pandemic underperformers are set to boom as the economy reopens. Scott Levine (Ecolab): Of the many stocks that have suffered over the past year, one I have a close eye on is Ecolab.
Ecolab Inc. President and CEO Christophe Beck will address financial analysts virtually at the G.research Specialty Chemicals Conference on Thursday, March 11, 2021. Ecolab will offer a live webcast of Mr. Beck’s presentation. Updated details for the webcast are as follows:
Ecolab Inc. President and CEO Christophe Beck will address financial analysts virtually at the G.research Specialty Chemicals Conference on Thursday, March 11, 2021. Ecolab will offer a live webcast of Mr. Beck’s presentation. Details for the webcast are as follows: